Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: peptide-based immunotherapeutics - Bionor Holding

Next Previous
X
Search
Drug Profile

Research programme: peptide-based immunotherapeutics - Bionor Holding

Alternative Names: Vacc CMV; Vacc Flu; Vacc HCV; Vacc HPV; Vacc-CMV (cytomegalovirus vaccine) - Bionor Holding; Vacc-Flu (universal influenza vaccine) - Bionor Holding; Vacc-HCV (hepatitis C vaccine) - Bionor Holding; Vacc-HIV; Vacc-HPV (human papillomavirus vaccine) - Bionor Holding

Latest Information Update: 27 Dec 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bionor Immuno
  • Developer Bionor Holding
  • Class Peptides; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cervical cancer; Cytomegalovirus infections; Hepatitis C; Human papillomavirus infections; Influenza virus infections

Highest Development Phases

  • No development reported Cervical cancer; Hepatitis C; HIV infections; Human papillomavirus infections; Influenza virus infections

Most Recent Events

  • 27 Dec 2022 Discontinued - Preclinical for HIV infections in United Kingdom (Parenteral)
  • 28 Jul 2020 No recent reports of development identified for preclinical development in HIV-infections in United Kingdom (Parenteral)
  • 28 Jul 2018 No recent reports of development identified for preclinical development in Cervical-cancer(Prevention) in Norway (Parenteral)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top